{"Abdominal rigidity": 5.0274011211432885, "Acute myeloid leukaemia": 8.81641094338189, "Acute promyelocytic leukaemia": 10.780904969572008, "Acute respiratory distress syndrome": 2.415359606715911, "Adenocarcinoma": 12.611528695925712, "Agranulocytosis": 10.3036632236459, "Alopecia": 4.85766469823197, "Alopecia areata": 11.620491977987236, "Alopecia totalis": 16.11649467259715, "Anaemia": 2.573123446414012, "Aortitis": 15.008312570377834, "Bacteraemia": 2.676943400840561, "Bicytopenia": 24.457864657019265, "Bone lesion": 7.042013162264041, "Bone marrow failure": 2.0248612367122547, "Bone pain": 2.479294309095321, "Breast cancer": 2.2611314101877427, "Breast cancer female": 3.4050415744625635, "Breast cancer metastatic": 14.596554217244952, "Breast cancer recurrent": 22.72097530100633, "Breast mass": 2.299763002844361, "Cancer pain": 5.907358770710211, "Candida sepsis": 17.743435841229733, "Carbohydrate antigen 15-3 increased": 13.519236850514938, "Carbon dioxide decreased": 14.259758772707125, "Cardiac dysfunction": 4.618435820008648, "Cardiac failure": 2.743600572402576, "Cardiomyopathy": 3.410836650269024, "Cardiotoxicity": 21.50628019338558, "Chemotherapy": 12.070621251638403, "Chronic myeloid leukaemia": 2.7157715451279856, "Cytopenia": 6.392497593129625, "Dacryostenosis acquired": 55.20843720460139, "Decreased appetite": 2.684675632532356, "Device related infection": 3.839835594120896, "Diarrhoea": 3.0779379361781616, "Dilated cardiomyopathy": 2.767484724194341, "Disease progression": 8.223591989799681, "Disease recurrence": 2.616318439607925, "Drug resistance": 2.057054354931867, "Ejection fraction decreased": 19.65072698574972, "Enteritis": 8.504612285310422, "Enterocolitis": 5.289659659040225, "Eosinophil count decreased": 10.160438199064352, "Febrile neutropenia": 28.629989018094147, "Gastrointestinal necrosis": 5.148365347366503, "Gastrointestinal toxicity": 8.472649627069885, "Granulocyte count decreased": 29.800393023951813, "Granulocytopenia": 16.79507584085875, "HER2 positive breast cancer": 60.193124052351465, "Haematotoxicity": 16.659864057754387, "Hair colour changes": 10.749513942419506, "Hair texture abnormal": 19.596889298428984, "Hepatic function abnormal": 3.6457136427803016, "Hepatic lesion": 4.083193753420265, "Hormone-refractory prostate cancer": 31.411306147416752, "Hypoalbuminaemia": 3.4260906695037123, "Hypocalcaemia": 2.876503960970272, "Hypomagnesaemia": 2.303220014465062, "Ileus paralytic": 6.386699811510123, "Interstitial lung disease": 4.069747627390993, "Intestinal obstruction": 2.520114377391215, "Invasive ductal breast carcinoma": 6.916077914407778, "Lacrimation increased": 2.3124370944806736, "Large intestine perforation": 4.96821987938351, "Left ventricular dysfunction": 12.841853667874345, "Leukoencephalopathy": 4.174868794844409, "Leukopenia": 8.144491404671667, "Lower limb fracture": 2.212977942913557, "Lung adenocarcinoma": 14.32010390380113, "Lymphocyte count decreased": 4.09413321701253, "Lymphopenia": 2.916998146469159, "Madarosis": 28.62631686126565, "Malignant neoplasm progression": 6.9591864826706935, "Mastectomy": 9.740352953705187, "Metastases to bone": 18.2038678386517, "Metastases to central nervous system": 9.548306702064526, "Metastases to liver": 13.09151542299708, "Metastases to lung": 15.802891653483467, "Metastases to lymph nodes": 19.005162707479982, "Metastases to peritoneum": 4.363921412940717, "Metastases to pleura": 12.563735743835828, "Metastases to skin": 18.27070930325796, "Metastases to spine": 4.507200981192674, "Metastases to the mediastinum": 46.5887650351626, "Metastasis": 21.231728302693725, "Mouth ulceration": 2.1569063492458667, "Mucosal inflammation": 11.178585162236107, "Myelodysplastic syndrome": 4.956878666132281, "Myelosuppression": 48.87542607231311, "Nail disorder": 14.730235569039053, "Nasal disorder": 13.993811534848758, "Neoplasm progression": 3.9198804299140657, "Neoplasm recurrence": 16.69695529630055, "Neuropathy peripheral": 4.93420867254042, "Neurotoxicity": 4.226472316353257, "Neutropenia": 8.793105132092522, "Neutropenic colitis": 23.714571167964287, "Neutropenic sepsis": 7.721431403401235, "Neutrophil count decreased": 34.62284664653982, "Neutrophil count increased": 3.8805571486384896, "Non-small cell lung cancer": 17.513567983371544, "Oesophagitis": 3.05545288688317, "Onycholysis": 18.733947733431304, "Osteonecrosis of jaw": 3.95164622060144, "Palmar-plantar erythrodysaesthesia syndrome": 4.537346373477682, "Paronychia": 5.434291712191003, "Peripheral sensory neuropathy": 4.2701728296195975, "Peritonitis": 2.213287758370078, "Platelet count decreased": 2.001522640333396, "Pleural effusion": 3.3046122868531937, "Pneumatosis intestinalis": 5.05545290243944, "Pneumocystis jirovecii pneumonia": 2.569518615565977, "Pneumonitis": 2.8645296967622027, "Polyneuropathy": 8.979708297874323, "Portal venous gas": 56.970378319483046, "Prostate cancer": 3.8956577990466297, "Prostate cancer metastatic": 32.33352066749576, "Prostatic specific antigen increased": 15.147151532881155, "Pulmonary mass": 2.9177652190086456, "Red cell distribution width increased": 7.109199533740688, "Second primary malignancy": 7.364305891823765, "Septic shock": 3.8393598819895898, "Skin toxicity": 10.563897447393977, "Stomatitis": 4.550902949148209, "Subacute cutaneous lupus erythematosus": 9.677926406363946, "Subclavian vein thrombosis": 36.32492223547745, "Systemic scleroderma": 38.20877824310973, "Therapy partial responder": 7.709591095369095, "Tongue ulceration": 6.125723691725801, "Tonsillar disorder": 36.66135298200761, "Troponin I increased": 8.995577780153678, "Tumour lysis syndrome": 3.305037123296783, "Uterine leiomyoma": 3.558386868311663, "Uterine leiomyosarcoma": 92.37019843880036, "Vascular device infection": 4.411997310390493, "White blood cell count decreased": 23.80176721955633, "White blood cell count increased": 2.098273468327702}